{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-178083","form_type":"8-K","ticker":"WVE","cik":"0001631574","company_name":"Wave Life Sciences Ltd.","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.524513+00:00","generated_at":"2026-05-17T15:29:57.032516+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Wave Life Sciences shareholders approve 8M share increase to equity plan","bullets":["Shareholders approved 8M share increase to 2021 Equity Incentive Plan (105.9M for, 24.6M against).","All nine director nominees re-elected, including Paul Bolno and Christian Henry.","KPMG ratified as independent auditor for FY2025 with 144.5M votes for.","Advisory executive compensation vote passed with 129.6M for; shareholders favored annual frequency (130.2M for one-year)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-178083","json":"https://secwatch.observer/filing/0001193125-25-178083.json","markdown":"https://secwatch.observer/filing/0001193125-25-178083.md","text":"https://secwatch.observer/filing/0001193125-25-178083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525178083/0001193125-25-178083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525178083/d35789d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:29:57.032516+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}